{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T03:26:14Z","timestamp":1772249174980,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T00:00:00Z","timestamp":1688947200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T00:00:00Z","timestamp":1688947200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005366","name":"University of Oslo","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005366","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>To analyze tumor characteristics derived from pelvic magnetic resonance imaging (MRI) of patients with squamous cell carcinoma of the anus (SCCA) before and during chemoradiotherapy (CRT), and to compare the changes in these characteristics between scans of responders vs. nonresponders to CRT.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We included 52\u00a0patients with a\u00a0pelvic 3T MRI scan prior to CRT (baseline scan); 39\u00a0of these patients received an additional scan during week\u00a02 of CRT (second scan). Volume, diameter, extramural tumor depth (EMTD), and external anal sphincter infiltration (EASI) of the tumor were assessed. Mean, kurtosis, skewness, standard deviation (SD), and entropy values were extracted from apparent diffusion coefficient (ADC) histograms. The main outcome was locoregional treatment failure. Correlations were evaluated with Wilcoxon\u2019s signed rank-sum test and Pearson\u2019s correlation coefficient, quantile regression, univariate logistic regression, and area under the ROC curve (AUC) analyses.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In isolated analyses of the baseline and second MRI scans, none of the characteristics were associated with outcome. Comparison between the scans showed significant changes in several characteristics: volume, diameter, EMTD, and ADC skewness decreased in the second scan, although the mean ADC increased. Small decreases in volume and diameter were associated with treatment failure, and these variables had the highest AUC values (0.73 and 0.76, respectively) among the analyzed characteristics.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Changes in tumor volume and diameter in an early scan during CRT could represent easily assessable imaging-based biomarkers to eliminate the need for analysis of more complex MRI characteristics.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00066-023-02114-5","type":"journal-article","created":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T19:03:17Z","timestamp":1689015797000},"page":"19-27","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Magnetic resonance imaging of anal cancer: tumor characteristics and early prediction of treatment outcome"],"prefix":"10.1007","volume":"200","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3094-6548","authenticated-orcid":false,"given":"Bettina A.","family":"Hanekamp","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen","family":"Viktil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathinka S.","family":"Sl\u00f8rdahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johann Baptist","family":"Dormagen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nils E.","family":"Kl\u00f8w","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eirik","family":"Malinen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cathrine","family":"Brunborg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianne G.","family":"Guren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anselm","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,10]]},"reference":[{"issue":"3","key":"2114_CR1","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1093\/ije\/dyw276","volume":"46","author":"F Islami","year":"2017","unstructured":"Islami\u00a0F, Ferlay\u00a0J, Lortet-Tieulent\u00a0J, Bray\u00a0F, Jemal\u00a0A (2017) International trends in anal cancer incidence rates. Int J Epidemiol 46(3):924\u2013938. https:\/\/doi.org\/10.1093\/ije\/dyw276","journal-title":"Int J Epidemiol"},{"issue":"16","key":"2114_CR2","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1001\/jama.299.16.1914","volume":"299","author":"JA Ajani","year":"2008","unstructured":"Ajani\u00a0JA, Winter\u00a0KA, Gunderson\u00a0LL, Pedersen\u00a0J, Benson\u00a0AB, Thomas\u00a0CR et\u00a0al (2008) Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial. JAMA 299(16):1914\u20131921. https:\/\/doi.org\/10.1001\/jama.299.16.1914","journal-title":"JAMA"},{"issue":"6","key":"2114_CR3","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/S1470-2045(13)70086-X","volume":"14","author":"RD James","year":"2013","unstructured":"James\u00a0RD, Glynne-Jones\u00a0R, Meadows\u00a0HM, Cunningham\u00a0D, Myint\u00a0AS, Saunders\u00a0MP et al (2013) Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a\u00a0randomised, phase 3, open-label, 2\u00d72 factorial trial. Lancet Oncol 14(6):516\u2013524. https:\/\/doi.org\/10.1016\/S1470-2045(13)70086-X","journal-title":"Lancet Oncol"},{"issue":"3","key":"2114_CR4","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.radonc.2014.04.013","volume":"111","author":"R Glynne-Jones","year":"2014","unstructured":"Glynne-Jones\u00a0R, Nilsson\u00a0PJ, Aschele\u00a0C, Goh\u00a0V, Peiffert\u00a0D, Cervantes\u00a0A et al (2014) Anal cancer: ESMO\u2013ESSO\u2013ESTRO clinical practice guidelines for diagnosis, treatment and follow-up. Radiother Oncol 111(3):330\u2013339. https:\/\/doi.org\/10.1016\/j.radonc.2014.04.013","journal-title":"Radiother Oncol"},{"issue":"9","key":"2114_CR5","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.annonc.2021.06.015","volume":"32","author":"S Rao","year":"2021","unstructured":"Rao\u00a0S, Guren\u00a0MG, Khan\u00a0K, Brown\u00a0G, Renehan\u00a0AG, Steigen\u00a0SE et al (2021) Anal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 32(9):1087\u20131100. https:\/\/doi.org\/10.1016\/j.annonc.2021.06.015","journal-title":"Ann Oncol"},{"issue":"16","key":"2114_CR6","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1200\/JCO.2011.35.4837","volume":"30","author":"D Peiffert","year":"2012","unstructured":"Peiffert\u00a0D, Tournier-Rangeard\u00a0L, Gerard\u00a0J\u2011P, Lemanski\u00a0C, Francois\u00a0E, Giovannini\u00a0M et al (2012) Induction chemotherapy and dose intensification of the radiation boost in locally advanced anal canal carcinoma: final analysis of the randomized UNICANCER ACCORD 03 trial. J\u00a0Clin Oncol 30(16):1941\u20131948. https:\/\/doi.org\/10.1200\/JCO.2011.35.4837","journal-title":"J Clin Oncol"},{"issue":"2","key":"2114_CR7","doi-asserted-by":"publisher","first-page":"e173","DOI":"10.1016\/j.ijrobp.2011.12.062","volume":"83","author":"AG Bentzen","year":"2012","unstructured":"Bentzen\u00a0AG, Guren\u00a0MG, Wander\u00e5s\u00a0EH, Frykholm\u00a0G, Tveit\u00a0KM, Wilsgaard\u00a0T et\u00a0al (2012) Chemoradiotherapy of anal carcinoma: survival and recurrence in an unselected national cohort. Int J Radiat Oncol Biol Phys 83(2):e173\u2013e180. https:\/\/doi.org\/10.1016\/j.ijrobp.2011.12.062","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"3","key":"2114_CR8","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.radonc.2014.10.002","volume":"113","author":"O Leon","year":"2014","unstructured":"Leon\u00a0O, Guren\u00a0M, Hagberg\u00a0O, Glimelius\u00a0B, Dahl\u00a0O, Havsteen\u00a0H et\u00a0al (2014) Anal carcinoma\u2014survival and recurrence in a\u00a0large cohort of patients treated according to nordic guidelines. (Report). Radiother Oncol 113(3):352. https:\/\/doi.org\/10.1016\/j.radonc.2014.10.002","journal-title":"Radiother Oncol"},{"issue":"5","key":"2114_CR9","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1002\/bjs.4908","volume":"92","author":"AG Renehan","year":"2005","unstructured":"Renehan\u00a0AG, Saunders\u00a0MP, Schofield\u00a0PF, O\u2019Dwyer\u00a0ST (2005) Patterns of local disease failure and outcome after salvage surgery in patients with anal cancer. Br J Surg 92(5):605\u2013614. https:\/\/doi.org\/10.1002\/bjs.4908","journal-title":"Br J Surg"},{"issue":"12","key":"2114_CR10","doi-asserted-by":"publisher","first-page":"3613","DOI":"10.1007\/s00520-015-2879-2","volume":"23","author":"SC Sodergren","year":"2015","unstructured":"Sodergren\u00a0SC, Vassiliou\u00a0V, Dennis\u00a0K, Tomaszewski\u00a0KA, Gilbert\u00a0A, Glynne-Jones\u00a0R et al (2015) Systematic review of the quality of life issues associated with anal cancer and its treatment with radiochemotherapy. Support Care Cancer 23(12):3613\u20133623. https:\/\/doi.org\/10.1007\/s00520-015-2879-2","journal-title":"Support Care Cancer"},{"issue":"4","key":"2114_CR11","doi-asserted-by":"publisher","first-page":"736","DOI":"10.3109\/0284186X.2013.770599","volume":"52","author":"AG Bentzen","year":"2013","unstructured":"Bentzen\u00a0AG, Balteskard\u00a0L, Wander\u00e5s\u00a0EH, Frykholm\u00a0G, Wilsgaard\u00a0T, Dahl\u00a0O et al (2013) Impaired health-related quality of life after chemoradiotherapy for anal cancer: late effects in a\u00a0national cohort of 128 survivors. Acta Oncol 52(4):736. https:\/\/doi.org\/10.3109\/0284186X.2013.770599","journal-title":"Acta Oncol"},{"issue":"4","key":"2114_CR12","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.clcc.2021.09.006","volume":"20","author":"MG Guren","year":"2021","unstructured":"Guren\u00a0MG, Sebag-Montefiore\u00a0D, Franco\u00a0P, Johnsson\u00a0A, Segelov\u00a0E, Deutsch\u00a0E et al (2021) Treatment of squamous cell carcinoma of the anus, unresolved areas and future perspectives for research: perspectives of research needs in anal cancer. Clin Colorectal Cancer 20(4):279\u2013287. https:\/\/doi.org\/10.1016\/j.clcc.2021.09.006","journal-title":"Clin Colorectal Cancer"},{"key":"2114_CR13","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/jmri.26058","volume":"48","author":"I Dregely","year":"2018","unstructured":"Dregely\u00a0I, Prezzi\u00a0D, Kelly-Morland\u00a0C, Roccia\u00a0E, Neji\u00a0R, Goh\u00a0V (2018) Imaging biomarkers in oncology: basics and application to MRI. J\u00a0Magn Reson Imaging 48:13\u201326. https:\/\/doi.org\/10.1002\/jmri.26058","journal-title":"J Magn Reson Imaging"},{"key":"2114_CR14","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ejca.2018.07.131","volume":"104","author":"MRS Siddiqui","year":"2018","unstructured":"Siddiqui\u00a0MRS, Simillis\u00a0C, Bhoday\u00a0J, Battersby\u00a0NJ, Mok\u00a0J, Rasheed\u00a0S et al (2018) A meta-analysis assessing the survival implications of subclassifying T3 rectal tumours. Eur J Cancer 104:47\u201361. https:\/\/doi.org\/10.1016\/j.ejca.2018.07.131","journal-title":"Eur J Cancer"},{"issue":"2","key":"2114_CR15","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1593\/neo.81328","volume":"11","author":"AR Padhani","year":"2009","unstructured":"Padhani\u00a0AR, Liu\u00a0G, Mu-Koh\u00a0D, Chenevert\u00a0TL, Thoeny\u00a0HC, Takahara\u00a0T et al (2009) Diffusion-weighted magnetic resonance imaging as a\u00a0cancer biomarker: consensus and recommendations. Neoplasia 11(2):102\u2013125. https:\/\/doi.org\/10.1593\/neo.81328","journal-title":"Neoplasia"},{"issue":"3","key":"2114_CR16","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1158\/1078-0432.CCR-08-1287","volume":"15","author":"S Kim","year":"2009","unstructured":"Kim\u00a0S, Loevner\u00a0L, Quon\u00a0H, Sherman\u00a0E, Weinstein\u00a0G, Kilger\u00a0A et al (2009) Diffusion-weighted magnetic resonance imaging for predicting and detecting early response to chemoradiation therapy of squamous cell carcinomas of the head and neck. Clin Cancer Res 15(3):986. https:\/\/doi.org\/10.1158\/1078-0432.CCR-08-1287","journal-title":"Clin Cancer Res"},{"issue":"9","key":"2114_CR17","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1007\/s00330-010-1769-8","volume":"20","author":"A King","year":"2010","unstructured":"King\u00a0A, Mo\u00a0F, Yu\u00a0K\u2011H, Yeung\u00a0D, Zhou\u00a0H, Bhatia\u00a0K et al (2010) Squamous cell carcinoma of the head and neck: diffusion-weighted MR imaging for prediction and monitoring of treatment response. Eur Radiol 20(9):2213\u20132220. https:\/\/doi.org\/10.1007\/s00330-010-1769-8","journal-title":"Eur Radiol"},{"issue":"7","key":"2114_CR18","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1007\/s00330-010-1734-6","volume":"20","author":"V Vandecaveye","year":"2010","unstructured":"Vandecaveye\u00a0V, Dirix\u00a0P, Keyzer\u00a0F, Op de Beeck\u00a0K, Poorten\u00a0V, Roebben\u00a0I et al (2010) Predictive value of diffusion-weighted magnetic resonance imaging during chemoradiotherapy for head and neck squamous cell carcinoma. Eur Radiol 20(7):1703\u20131714. https:\/\/doi.org\/10.1007\/s00330-010-1734-6","journal-title":"Eur Radiol"},{"issue":"2","key":"2114_CR19","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.ygyno.2008.07.048","volume":"111","author":"VN Harry","year":"2008","unstructured":"Harry\u00a0VN, Semple\u00a0SI, Gilbert\u00a0FJ, Parkin\u00a0DE (2008) Diffusion-weighted magnetic resonance imaging in the early detection of response to chemoradiation in cervical cancer. Gynecol Oncol 111(2):213\u2013220. https:\/\/doi.org\/10.1016\/j.ygyno.2008.07.048","journal-title":"Gynecol Oncol"},{"key":"2114_CR20","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2016.34.4_suppl.503","author":"V Desiato","year":"2016","unstructured":"Desiato\u00a0V, Rosman\u00a0A, Newman\u00a0E, Berman\u00a0R, Pachter\u00a0HL, Melis\u00a0M (2016) Changes in apparent diffusion coefficient evaluated with diffusion-weighted MRI to predict complete pathologic response after neoadjuvant therapy for rectal cancer: literature review and meta-analysis. J\u00a0Clin Oncol. https:\/\/doi.org\/10.1200\/jco.2016.34.4_suppl.503","journal-title":"J Clin Oncol"},{"issue":"2","key":"2114_CR21","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.radonc.2014.11.026","volume":"113","author":"I Joye","year":"2014","unstructured":"Joye\u00a0I, Deroose\u00a0CM, Vandecaveye\u00a0V, Haustermans\u00a0K (2014) The role of diffusion-weighted MRI and 18F-FDG PET\/CT in the prediction of pathologic complete response after radiochemotherapy for rectal cancer: a systematic review. Radiother Oncol 113(2):158\u2013165. https:\/\/doi.org\/10.1016\/j.radonc.2014.11.026","journal-title":"Radiother Oncol"},{"issue":"7","key":"2114_CR22","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.1007\/s00330-017-5284-z","volume":"28","author":"A Hocquelet","year":"2018","unstructured":"Hocquelet\u00a0A, Auriac\u00a0T, Perier\u00a0C, Dromain\u00a0C, Meyer\u00a0M, Pinaquy\u00a0JB et al (2018) Pre-treatment magnetic resonance-based texture features as potential imaging biomarkers for predicting event free survival in anal cancer treated by chemoradiotherapy. Eur Radiol 28(7):2801\u20132811. https:\/\/doi.org\/10.1007\/s00330-017-5284-z","journal-title":"Eur Radiol"},{"key":"2114_CR23","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.radonc.2019.01.022","volume":"134","author":"K Owczarczyk","year":"2019","unstructured":"Owczarczyk\u00a0K, Prezzi\u00a0D, Cascino\u00a0M, Kozarski\u00a0R, Gaya\u00a0A, Siddique\u00a0M et\u00a0al (2019) MRI heterogeneity analysis for prediction of recurrence and disease free survival in anal cancer. Radiother Oncol 134:119\u2013126. https:\/\/doi.org\/10.1016\/j.radonc.2019.01.022","journal-title":"Radiother Oncol"},{"key":"2114_CR24","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.radonc.2019.10.001","volume":"144","author":"M Jones","year":"2020","unstructured":"Jones\u00a0M, Hruby\u00a0G, Coolens\u00a0C, Driscoll\u00a0B, Stanwell\u00a0P, Kumar\u00a0M et al (2020) A prospective, multi-centre trial of multi-parametric MRI as a\u00a0biomarker in anal carcinoma. Radiother Oncol 144:7\u201312. https:\/\/doi.org\/10.1016\/j.radonc.2019.10.001","journal-title":"Radiother Oncol"},{"issue":"12","key":"2114_CR25","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.clon.2020.09.003","volume":"32","author":"R Muirhead","year":"2020","unstructured":"Muirhead\u00a0R, Bulte\u00a0D, Cooke\u00a0R, Chu\u00a0KY, Durrant\u00a0L, Goh\u00a0V et al (2020) A prospective study of diffusion-weighted magnetic resonance imaging as an early prognostic biomarker in chemoradiotherapy in squamous cell carcinomas of the anus. Clin Oncol (R Coll Radiol) 32(12):874\u2013883. https:\/\/doi.org\/10.1016\/j.clon.2020.09.003","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"7","key":"2114_CR26","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1080\/0284186X.2021.1918763","volume":"60","author":"KS Sl\u00f8rdahl","year":"2021","unstructured":"Sl\u00f8rdahl\u00a0KS, Klotz\u00a0D, Olsen\u00a0J\u2011\u00c5, Skovlund\u00a0E, Undseth\u00a0C, Abildgaard\u00a0HL et al (2021) Treatment outcomes and prognostic factors after chemoradiotherapy for anal cancer. Acta Oncol 60(7):921\u2013930. https:\/\/doi.org\/10.1080\/0284186X.2021.1918763","journal-title":"Acta Oncol"},{"key":"2114_CR27","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/bjs.4034","volume":"90","author":"G Brown","year":"2003","unstructured":"Brown\u00a0G, Radcliffe\u00a0AG, Newcombe\u00a0RG, Dallimore\u00a0NS, Bourne\u00a0MW, Williams\u00a0GT (2003) Preoperative assessment of prognostic factors in rectal cancer using high-resolution magnetic resonance imaging. Br J Surg 90:355. https:\/\/doi.org\/10.1002\/bjs.4034","journal-title":"Br J Surg"},{"issue":"16","key":"2114_CR28","doi-asserted-by":"publisher","first-page":"4786","DOI":"10.1158\/0008-5472.Can-18-0125","volume":"78","author":"C Nioche","year":"2018","unstructured":"Nioche\u00a0C, Orlhac\u00a0F, Boughdad\u00a0S, Reuz\u00e9\u00a0S, Goya-Outi\u00a0J, Robert\u00a0C et al (2018) LIFEx: a freeware for radiomic feature calculation in multimodality imaging to accelerate advances in the characterization of tumor heterogeneity. Cancer Res 78(16):4786\u20134789. https:\/\/doi.org\/10.1158\/0008-5472.Can-18-0125","journal-title":"Cancer Res"},{"issue":"23","key":"2114_CR29","doi-asserted-by":"publisher","first-page":"2676","DOI":"10.1002\/sim.4509","volume":"31","author":"X Liu","year":"2012","unstructured":"Liu\u00a0X (2012) Classification accuracy and cut point selection. Statist Med 31(23):2676\u20132686. https:\/\/doi.org\/10.1002\/sim.4509","journal-title":"Statist Med"},{"key":"2114_CR30","volume-title":"TNM classification of malignant tumours","author":"J Brierley","year":"2017","unstructured":"Brierley\u00a0J, Gospodarwicz\u00a0MK, Wittekind\u00a0C (2017) TNM classification of malignant tumours, 8th\u00a0edn. John Wiley  Sons, Inc, Chichester, West Sussex, UK,Hoboken, NJ","edition":"8"},{"issue":"3","key":"2114_CR31","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1007\/s11888-016-0321-x","volume":"12","author":"S Balyasnikova","year":"2016","unstructured":"Balyasnikova\u00a0S, Brown\u00a0G (2016) Imaging advances in colorectal cancer. Curr Colorectal Cancer Rep 12(3):162\u2013169. https:\/\/doi.org\/10.1007\/s11888-016-0321-x","journal-title":"Curr Colorectal Cancer Rep"},{"issue":"6","key":"2114_CR32","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s13244-012-0196-6","volume":"3","author":"F Davnall","year":"2012","unstructured":"Davnall\u00a0F, Yip\u00a0CSP, Ljungqvist\u00a0G, Selmi\u00a0M, Ng\u00a0F, Sanghera\u00a0B et\u00a0al (2012) Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice? Insights Imaging 3(6):573\u2013589. https:\/\/doi.org\/10.1007\/s13244-012-0196-6","journal-title":"Insights Imaging"},{"issue":"1","key":"2114_CR33","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1148\/radiol.2018171804","volume":"288","author":"N-E Enkhbaatar","year":"2018","unstructured":"Enkhbaatar\u00a0N\u2011E, Inoue\u00a0S, Yamamuro\u00a0H, Kawada\u00a0S, Miyaoka\u00a0M, Nakamura\u00a0N et al (2018) MR imaging with apparent diffusion coefficient histogram analysis: evaluation of locally advanced rectal cancer after chemotherapy and radiation therapy. Radiology 288(1):129\u2013137. https:\/\/doi.org\/10.1148\/radiol.2018171804","journal-title":"Radiology"},{"issue":"1","key":"2114_CR34","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1148\/radiol.11110577","volume":"261","author":"S Kyriazi","year":"2011","unstructured":"Kyriazi\u00a0S, Collins\u00a0DJ, Messiou\u00a0C, Pennert\u00a0K, Davidson\u00a0RL, Giles\u00a0SL et al (2011) Metastatic ovarian and primary peritoneal cancer: assessing chemotherapy response with diffusion-weighted MR imaging\u2014value of histogram analysis of apparent diffusion coefficients. Radiology 261(1):182\u2013192. https:\/\/doi.org\/10.1148\/radiol.11110577","journal-title":"Radiology"},{"key":"2114_CR35","doi-asserted-by":"publisher","first-page":"7555","DOI":"10.2147\/OTT.S111829","volume":"9","author":"F-J Ju","year":"2016","unstructured":"Ju\u00a0F\u2011J (2016) Evaluation of the efficacy of chemoradiotherapy in cervical cancer using diffusion-weighted imaging and apparent diffusion coefficient. Onco Targets Ther 9:7555\u20137561. https:\/\/doi.org\/10.2147\/OTT.S111829","journal-title":"Onco Targets Ther"},{"key":"2114_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13020193","author":"N Giraud","year":"2021","unstructured":"Giraud\u00a0N, Saut\u00a0O, Aparicio\u00a0T, Ronchin\u00a0P, Bazire\u00a0LA, Barbier\u00a0E et al (2021) MRI-based radiomics input for prediction of 2\u2011year disease recurrence in anal squamous cell carcinoma. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers13020193","journal-title":"Cancers (Basel)"},{"key":"2114_CR37","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.radonc.2021.03.013","volume":"159","author":"A Choudhury","year":"2021","unstructured":"Choudhury\u00a0A, Theophanous\u00a0S, L\u00f8nne\u00a0P\u2011I, Samuel\u00a0R, Guren\u00a0MG, Berbee\u00a0M et al (2021) Predicting outcomes in anal cancer patients using multi-centre data and distributed learning\u2014a proof-of-concept study. Radiother Oncol 159:183\u2013189. https:\/\/doi.org\/10.1016\/j.radonc.2021.03.013","journal-title":"Radiother Oncol"},{"issue":"1","key":"2114_CR38","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ijrobp.2014.09.028","volume":"91","author":"CP Coolens","year":"2015","unstructured":"Coolens\u00a0CP, Driscoll\u00a0BM, Chung\u00a0CMDF, Shek\u00a0TM, Gorjizadeh\u00a0AB, M\u00e9nard\u00a0CMDF et al (2015) Automated voxel-based analysis of volumetric dynamic contrast-enhanced CT data improves measurement of serial changes in tumor vascular biomarkers. Int J Radiat Oncol Biol Phys 91(1):48\u201357. https:\/\/doi.org\/10.1016\/j.ijrobp.2014.09.028","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-023-02114-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00066-023-02114-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-023-02114-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T18:02:27Z","timestamp":1704996147000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00066-023-02114-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,10]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["2114"],"URL":"https:\/\/doi.org\/10.1007\/s00066-023-02114-5","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,10]]},"assertion":[{"value":"23 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"B.A.\u00a0Hanekamp, E.\u00a0Viktil, K.S.\u00a0Sl\u00f8rdahl, J.B.\u00a0Dormagen, N.E.\u00a0Kl\u00f8w, E.\u00a0Malinen, C.\u00a0Brunborg, M.G.\u00a0Guren, and A.\u00a0Schulz declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki and was approved by the Regional Ethical Committee South\u2013East (2012\/2274) and the local data protection officer. All patients provided written informed consent to participate in the study and regarding publishing their data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}